# Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients

> **NCT01651598** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 57 (actual)

## Conditions studied

- Healthy
- Asthma

## Interventions

- **DRUG:** Placebo to BI 144807
- **DRUG:** BI 144807

## Key facts

- **NCT ID:** NCT01651598
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2013-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01651598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01651598, "Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01651598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*